What is the Market's View on Surface Oncology Inc (SURF) Stock's Price and Volume Trends Friday?

Friday, April 16, 2021 11:00 AM | InvestorsObserver Analysts

Mentioned in this article

The market has been down on Surface Oncology Inc (SURF) stock recently. SURF gets a Bearish score from InvestorsObserver's Stock Sentiment Indicator.

Surface Oncology Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on SURF!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.

As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.

Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.

InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.

For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With SURF Stock Today?

Surface Oncology Inc (SURF) stock is down -7.68% while the S&P 500 is up 0.26% as of 10:58 AM on Friday, Apr 16. SURF is lower by -$0.55 from the previous closing price of $7.16 on volume of 834,678 shares. Over the past year the S&P 500 has gained 50.22% while SURF is up 153.26%. SURF earned $1.56 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 4.25.

To see the top 5 stocks in the Biotechnology industry click here.

More About Surface Oncology Inc

Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses. The company's pipeline products are SRF231, SRF373, SRF617, and SRF388. Geographically, the activities are carried out through the region of the United States.

Click Here to get the full Stock Score Report on Surface Oncology Inc (SURF) Stock.

Share this article: